Photodynamic Therapy (PDT) for Poor Prognosis Recurrent/Refractory Malignant Brain Tumors - A Phase I Study
Phase of Trial: Phase I
Latest Information Update: 27 Feb 2019
At a glance
- Drugs Porfimer sodium (Primary)
- Indications Brain cancer
- Focus Adverse reactions
- 21 Feb 2019 Status changed from recruiting to completed.
- 02 Dec 2016 Status changed from active, no longer recruiting to recruiting.
- 31 May 2016 Planned End Date changed from 1 Apr 2021 to 1 Apr 2024.